
3.03BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US24823R1059
CUSIP
24823R105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.23
Dividend Share
-
Dividend Yield
-
Earnings Share
-2.84
Wall Street Target Price
35.50
EPS Estimate Current Year
-2.23
EPS Estimate Next Year
-2.42
EPS Estimate Current Quarter
-0.4674
EPS Estimate Next Quarter
-0.6444
Most Recent Quarter
-
Revenue TTM
3,604,000
Gross Profit TTM
-397,208,992
EBITDA
-526,057,984
Profit Margin
0.00%
Return On Assets TTM
-29.15%
Return On Equity TTM
-54.93%
Revenue Per Share TTM
0.02
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-2.84
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
836.4934
Price Book MRQ
3.625
Enterprise Value Revenue
651
Enterprise Value EBITDA
86
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%